Home
 /
Papers
 /
Cancer Biology
 /
Extrachromosomal DNA micronucleation constrains tumour fitness and improves patient survival
Preprint
Open access
V1
Top 1% · Validated by QED

Extrachromosomal DNA micronucleation constrains tumour fitness and improves patient survival

Lotte Brückner, Robin Xu, Jun Tang +58 more
February 2026
 ·
bioRxiv
 ·
DOI 
10.1101/2025.04.15.648906
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Cancer Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By revealing that ecDNA mis-segregates into micronuclei—silencing oncogenes and killing daughter cells—this work overturns ecDNA's identity as a purely advantageous element and exposes an intrinsic fitness liability exploitable as a clinical biomarker.

QED claims analysis

Summary

Extrachromosomal DNA (ecDNA) frequently mis-segregates during mitosis through replication stress-induced clustered detachment mediated by the MDC1-CIP2A-TOPBP1 complex, resulting in collective sequestration of multiple distinct ecDNA species into transcriptionally silenced micronuclei that impose a cellular fitness penalty and correlate with improved survival in neuroblastoma patients, thereby revealing micronucleation as a constraint on ecDNA-driven oncogenesis.

See full analysis
Main Claim 1 –

ecDNA Frequently Localizes to Micronuclei in ecDNA-Positive Cancers

Supporting evidence

  • Micronuclei Frequency Scales with ecDNA Copy Number in Tumours
  • ecDNA Presence, Not Oncogene Expression, Drives Micronucleation
Main Claim 2 –

Mitotic ecDNA Clusters Detach and Form Single Daughter Micronuclei

Supporting evidence

  • MDC1–CIP2A–TOPBP1 Complex Mediates Damaged ecDNA Clustering in Mitosis
  • Replication Stress Drives Biased ecDNA Inheritance via Micronucleation
Main Claim 3 –

Replication Stress Promotes ecDNA Cluster Detachment and Micronucleation

Supporting evidence

  • Hydroxyurea Increases ecDNA-Oncogene Micronuclei Beyond Random Segregation
  • CRISPR-Induced ecDNA Damage Triggers Cluster Detachment and Micronuclei
Main Claim 4 –

Micronuclei Are Enriched for Coalesced, Multiple ecDNA Species

Supporting evidence

  • Distinct ecDNA Species Co-Enrich Correlatively Within Single Micronuclei
  • Damage to One ecDNA Species Induces Collective Micronucleation of Others

Abstract

Extrachromosomal DNA (ecDNA) contributes to cancer genome instability by enabling high-copy oncogene amplification, intratumoural heterogeneity and rapid genetic change. Micronuclei (MN) are frequently observed in chromosomally unstable cancers, yet their origins and relevance in ecDNA-driven tumours remain incompletely understood. Here, we investigate the relationship between ecDNA segregation errors and MN formation. We find that ecDNA frequently localizes to MN and represents a prominent source of MN content in ecDNA-positive cancer cells. Mitotic clustering of oncogene-bearing ecDNAs is associated with asymmetric inheritance and mis-segregation into MN. Transfer of oncogenes from ecDNA into MN is accompanied by reduced transcriptional output. Single-MN sequencing shows that individual MN are enriched for ecDNA to a degree that exceeds expectations from stochastic mis-segregation and that in MN oncogenes originating from multiple distinct ecDNAs coalesce. Using live-cell imaging, we observe that cells inheriting ecDNA-positive MN show limited proliferative capacity and an increased likelihood of cell death. In neuroblastoma patients with MYCN-amplified ecDNA, higher frequencies of ecDNA-positive MN at diagnosis are associated with improved event-free and overall survival. Together, these findings link ecDNA mis-segregation to MN formation and reduced cellular fitness, suggesting that ecDNA-positive MN may reflect a state of impaired oncogenic ecDNA function with potential relevance for clinical outcome.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?